ATLAS / Macro Radar / Reporting / CTOR

CITIUS ONCOLOGY, INC. (CTOR) reporting calendar

CITIUS ONCOLOGY, INC. files periodic reports with the SEC as CTOR on Nasdaq. Atlas tracks 15 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
20 Jul 2026 – 6 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
15 May 2026
Reports on record
15

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 44 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open CTOR market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202615 May 202645 days0001213900-26-057841
10-Q31 Dec 202513 Feb 202644 days0001213900-26-015877
10-K30 Sep 202523 Dec 202584 days0001213900-25-125331
10-Q30 Jun 202512 Aug 202543 days0001213900-25-074992
10-Q31 Mar 202514 May 202544 days0001213900-25-043359
10-Q31 Dec 202414 Feb 202545 days0001213900-25-014320
10-K30 Sep 202427 Dec 202488 days0001213900-24-113150
10-Q30 Jun 20249 Aug 202440 days0001493152-24-030991
10-Q31 Mar 202420 May 202450 days0001493152-24-020783
10-K31 Dec 202316 Apr 2024107 days0001493152-24-014850
10-Q30 Sep 202320 Nov 202351 days0001493152-23-042170
10-Q30 Jun 202316 Aug 202347 days0001493152-23-029131
10-Q31 Mar 202315 May 202345 days0001493152-23-017394
10-K31 Dec 202217 Apr 2023107 days0001493152-23-012545
10-Q30 Sep 202228 Nov 202259 days0001493152-22-033847

Source: SEC EDGAR company submissions for CIK 0001851484. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.